Loading...
XNAS
BCPC
Market cap5.38bUSD
May 13, Last price  
164.94USD
1D
-0.37%
1Q
3.62%
Jan 2017
96.54%
Name

Balchem Corp

Chart & Performance

D1W1MN
XNAS:BCPC chart
No data to show
P/E
41.88
P/S
5.64
EPS
3.94
Div Yield, %
Shrs. gr., 5y
0.13%
Rev. gr., 5y
8.18%
Revenues
954m
+3.39%
839,095,000100,905,000176,201,000232,050,000219,438,000255,071,000291,867,000310,393,000337,173,000541,383,000552,492,000553,204,000594,790,000643,679,000643,705,000703,644,000799,023,000942,358,000922,439,000953,684,000
Net income
128m
+18.36%
10,954,00012,278,00016,118,00019,050,00026,785,00033,277,00038,765,00040,005,00044,874,00052,826,00059,722,00055,972,00090,071,00078,573,00079,671,00084,623,00096,104,000105,367,000108,543,000128,475,000
CFO
182m
-0.96%
13,698,00016,370,00015,637,00022,897,00048,072,00039,030,00044,902,00053,781,00055,692,00085,350,000103,826,000107,612,000110,618,000118,697,000124,461,000150,494,000160,514,000138,536,000183,761,000181,999,000
Dividend
Dec 26, 20230.79 USD/sh
Earnings
Jul 24, 2025

Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
IPO date
Jun 03, 1986
Employees
1,284
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
953,684
3.39%
922,439
-2.11%
942,358
17.94%
Cost of revenue
770,775
765,563
797,172
Unusual Expense (Income)
NOPBT
182,909
156,876
145,186
NOPBT Margin
19.18%
17.01%
15.41%
Operating Taxes
37,978
28,718
28,382
Tax Rate
20.76%
18.31%
19.55%
NOPAT
144,931
128,158
116,804
Net income
128,475
18.36%
108,543
3.01%
105,367
9.64%
Dividends
(25,576)
(22,872)
(20,713)
Dividend yield
0.48%
0.47%
0.52%
Proceeds from repurchase of equity
(5,682)
(4,469)
(32,211)
BB yield
0.11%
0.09%
0.81%
Debt
Debt current
6,656
8,442
4,022
Long-term debt
52,095
346,878
460,610
Deferred revenue
Other long-term liabilities
190,000
68,623
42,833
Net debt
9,236
286,797
393,777
Cash flow
Cash from operating activities
181,999
183,761
138,536
CAPEX
(37,892)
(50,290)
Cash from investing activities
(59,736)
(34,813)
(416,014)
Cash from financing activities
(133,815)
(153,321)
246,679
FCF
135,323
141,552
17,151
Balance
Cash
49,515
64,447
66,560
Long term investments
4,076
4,295
Excess cash
1,831
22,401
23,737
Stockholders' equity
975,916
908,331
809,478
Invested Capital
1,382,117
1,434,761
1,399,691
ROIC
10.29%
9.04%
9.76%
ROCE
12.81%
10.77%
9.77%
EV
Common stock shares outstanding
32,718
32,448
32,393
Price
163.00
9.58%
148.75
21.82%
122.11
-27.57%
Market cap
5,332,870
10.49%
4,826,640
22.02%
3,955,509
-28.19%
EV
5,342,106
5,113,437
4,349,286
EBITDA
230,882
211,811
197,034
EV/EBITDA
23.14
24.14
22.07
Interest
16,528
22,613
10,268
Interest/NOPBT
9.04%
14.41%
7.07%